COMMUNIQUÉS West-GlobeNewswire

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial
23/04/2026
ACAPELLA is the European multicenter clinical trial evaluating Alpha DaRT alpha-emitter radiotherapeutics combined with capecitabine for inoperable LAPC patients who have completed first-line mFOLFIRINOX, a population [...]
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
23/04/2026
Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of Annamycin into a major unmet-need indication Significant tumor volume [...]
Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform
23/04/2026
DOVER, Del., April 23, 2026 (GLOBE NEWSWIRE) -- Theialife, a late-stage clinical company advancing innovative therapeutic solutions for ocular diseases, today announced the appointment of Thomas Ruggia as President and [...]
Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act
23/04/2026
BOCA RATON, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, applauds President Donald J. [...]
Neura Health to Expand Access to Migraine Care via LillyDirect
23/04/2026
The virtual neurology clinic also offers comprehensive specialty care for epilepsy, chronic pain, concussion, memory conditions, and more; appointments are available within seven days NEW YORK, April 23, 2026 (GLOBE [...]
Neocis and Yomi® S Named Winner of the 2026 TAG Awards for MedTech in Robotic & Procedural Innovation
23/04/2026
MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- Neocis®, the company behind the first and only FDA-cleared robotic system for dental implant surgery, today announced that Yomi® S has been named a winner of the 2026 TAG Awards [...]
H1 Launches Site Network Suite, the First AI-Powered Platform to Transform How Research Sites and Sponsors Engage on Clinical Trials
23/04/2026
H1’s Core AI Engine Helps Sponsors Find Sites More Efficiently and Determine Feasibility Faster, Bringing Process from Months to Weeks NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- H1 , the AI-powered platform that [...]
Heald Partners with Thatch Marketplace to Bring First-of-its-Kind Diabetes Reversal Program to Employees
23/04/2026
ALPHARETTA, Ga., April 23, 2026 (GLOBE NEWSWIRE) -- Heald, a leader in digital-first diabetes reversal, today announced a new partnership with Thatch, the modern health benefits platform. Through this collaboration, [...]
Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA
23/04/2026
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Lumina Therapy Alliance, the nation’s premier network of high-touch, in-person mental health practices, today announced that Wise Mind Institute, led by psychologist Dr. Wes [...]
Atsena Therapeutics Announces Upcoming Presentations at Scientific and Medical Meetings
23/04/2026
DURHAM, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced [...]
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
23/04/2026
BEIJING, April 23, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428) today announced its results and business highlights for the first quarter of 2026 as of 31 March 2026. Over the past decade, [...]
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
23/04/2026
- PRIDCor Therapeutics Granted Global Development and Commercialization License for IMC-1 and IMC-2 Assets for All Indications, including Fibromyalgia and Long-COVID - - Dogwood Granted a Tiered Royalty up to 15% on Net [...]
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
23/04/2026
ROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced its participation in Hacking the Vagus Nerve , a [...]
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
23/04/2026
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter [...]
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
23/04/2026
WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet [...]
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
23/04/2026
Nes-Ziona, Israel, April 23, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that it will present [...]
Women Are Ditching Generic Diets for Cycle-Based Wellness – This Cycle Diet App Review Explains Why
23/04/2026
A closer review of Cycle Diet reveals how phase-based nutrition and fitness tracking are changing the way women approach weight loss NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Cycle Diet, enters the women's health [...]
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
23/04/2026
CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report [...]
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
23/04/2026
PARAMUS, NJ, April 23, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying therapies for rare, pediatric lysosomal storage [...]

Pages